Blood Epidemiology and Clinical Therapeutics
Funding of clinical research in non-malignant blood diseases and cell therapies (e.g., hematopoietic stem cell transplants, transfusion products, and novel cell therapies) including epidemiologic studies, data science, patient-reported outcomes, observational clinical studies; and clinical trials that test therapeutic, behavioral, prevention, and/or implementation strategies.
Program Officers
Nahed El Kassar, M.D., Ph.D.
Hematologic clinical trials; Women’s health; HSCT late effects
301-435-0065
Shimian Zou, Ph.D.
NHLBI HIV/AIDS Coordinator Epidemiology, Transfusion
301-435-0065
Benyam Hailu, MD, MPH
Clinical studies; Transfusion; health disparities
301-435-0065
William P. Tonkins, Dr. PH, J.D.
Behavioral science; Sickle cell disease; Pain; PROs
301-435-0065